Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
Lenalidomide
×
Plasma cell
×
Clear all
Filters
3
NCT01953692
2021-08-04
MK-3475-013
Merck Sharp & Dohme LLC
Phase 1
Completed
197 enrolled
52 charts